Convatec - Chronically undervalued?

Buy Convatec (CTEC.L)

ConvaTec Group PLC is a United Kingdom-based medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.

Market Cap: £3.79Billion

The recovery over the medium term continues as the shares trade in a sequence of higher highs and higher lows. The recent corrective move back to the trend line has attracted some buying interest. The formation and break of a small wedge is also an encouraging sign that we can expect a continuation. There is an unfilled gap at 223p to target on the upside.

Stop: 181.6p
Target 1: 211p
Target 2: 222p
Target 3: 240p


Interested in UK Stocks?
Join our free Telegram channel for up to date analysis on the best main market opportunities in the UK right now - t.me/UK_Stocks
Chart PatternsconvatecCTECFTSEhealthcareTechnical IndicatorsinvestingisaSIPPTrend AnalysisUKUK100 CFD

Anche su:

Declinazione di responsabilità